About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Clover Health Investments, Corp. - Class A Common stock (NQ:CLOV)

2.665 +0.075 (+2.90%)
Streaming Delayed Price Updated: 11:27 AM EDT, Oct 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clover Health Investments, Corp. - Class A Common stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
24 25 Next >
CLOV Stock Price Predictions: Why One Analyst See Clover Health Shares Hitting $7
Clover Health Investments (CLOV) stock is on the move Wednesday following a new price prediction from Cowen analyst Gary Taylor. 
Via InvestorPlace
Expert Ratings For Clover Health Investments
Within the last quarter, Clover Health Investments (NASDAQ:CLOV) has observed the following analyst ratings: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022
Upgrades Oppenheimer upgraded the previous rating for NovoCure Ltd (NASDAQ:NVCR) from Perform to Outperform. NovoCure earned $0.13 in the third quarter, compared to $0.09... 
Via Benzinga
Clover Health Stock Remains a High-Risk High-Reward Play
Both Clover Health's bear and bull cases are equally compelling, which makes CLOV stock a highly risky bet right now. 
Via InvestorPlace
Clover Health Investments, Corp. (NASDAQ:CLOV) Investor Notice: Update in Lawsuit
San Diego, CA -- (SBWIRE) -- 02/02/2022 -- The Shareholders Foundation announced an update in the lawsuit that is pending for certain investors in shares of Clover Health Investments, Corp.... 
Via SBWire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Pharming (NASDAQ:PHAR) shares increased by 15.8% to $10.21 during Wednesday's pre-market session. The company's market cap stands at $652.2 million.... 
Via Benzinga
10 Biggest Price Target Changes For Wednesday
Keybanc lifted the price target for Alphabet Inc. (NASDAQ: GOOGL) from $3,090 to $3,400. Alphabet shares surged 11% to $3,055.00 in pre-market trading. 
Via Benzinga
7 Worst SPACs for Smart Investors to Skip in 2022
SPACs may make a comeback in 2022. But some of them won't ever recover. These 7 SPACs have a challenging future ahead of themselves. 
Via InvestorPlace
At Below $3 Clover Health Stock May Be Worth It as a Moonshot
It's unclear whether fortunes will turn around for CLOV stock this year, but among meme plays it may have the most comeback potential. 
Via InvestorPlace
Membership Growth Is Making Clover Health a More Convincing Investment
You can hold CLOV stock in hopes of another Reddit run-up, but there are also positive data points to support a long-term investment. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2022
Upgrades For Rocket Companies Inc (NYSE:RKT), JP Mo... 
Via Benzinga
Why Chamath Palihapitiya Is Facing Backlash For His Comments On Uyghur Genocide
Billionaire venture capitalist Chamath Palihapitiya is under fire for comments he made on a podcast dismissing human rights abuses against the Uyghurs in China. What Happened:... 
Via Benzinga
Clover Health Stock Investors Will Need to Buy Into Tech Chief’s Vision
CTO Andrew Toy's innovations like Clover Assistant, seen by some as savior of CLOV stock, are already being adopted by larger Medicare Advantage players. 
Via InvestorPlace
Camber Energy, Clover Health, Globalstar Stocks Continue Lower In Key Trend: Will The Bloodbath End?
Camber Energy, Inc (NYSE: CEI), Clover Health Investments Corp (NASDAQ: CLOV) and Globalstar, Inc (NYSE: GSAT) are all trading higher in strong downtrends. A downtrend occurs when... 
Via Benzinga
Clover Health Desperately Needs Triage, but It Isn’t Doomed Yet
Clover Health has a billion dollar yearly book of sales. Selloffs have limits, and we will soon find out if CLOV stock is a dud or a stud. 
Via InvestorPlace
Polestar Looks Like the Right EV Stock At the Wrong Time
Polestar has a lot of what I look for in a growth stock. But with valuations likely to correct further, there's no hurry to jump in now. 
Via InvestorPlace
RCL Stock Pressured by Hindenburg Short: 7 Things to Know
RCL stock is in the red since 2022 kicked off. Now, Hindenburg Research is taking full advantage of the cruise company's weaknesses. 
Via InvestorPlace
How Did the Meme Stocks Do Last Year? Here’s How
Quick, which ones were over 500% up? And which six were more than 45% down? 
Via Talk Markets
CLOV Stock Alert: 4 Things to Know as Clover Health Hits an All-Time Low
Shares of Clover Health are declining today due to Humana lowering its membership forecast and Credit Suisse issuing a downgrade. 
Via InvestorPlace
DeskTop Metal Shares Are Still Off Limits to Buyers
Off and on the price chart, there's work to be done in DM stock before bullish investors consider taking a long position. 
Via InvestorPlace
The Two Faces of Clover Health
The Clover Assistant may be great software, but the company behind it is questionable. CLOV Stock is best to be avoided for now. 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Friday
Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap... 
Via Benzinga
2021: The Year in Charts
A look at the charts and themes that tell the story of 2021. 
Via Talk Markets
The Steep Drop In Clover Health Stock Sets up an Entry Opportunity
Now that CLOV stock has lost considerable steam. Investors are looking for the company to consolidate and report positive earnings from here. 
Via InvestorPlace
Clover Health Is Not the $2 Billion Stock to Buy for 2022
Clover Health's market cap dropped 74% in 2021. As we head into 2022, CLOV stock is not the $2 billion market cap you want to buy. 
Via InvestorPlace
7 of The Best SPAC Stocks to Put on Your 2022 Watchlist
SPAC stocks may still be out of favor, but you'll still want to keep an eye on these seven picks with merger deals pending. 
Via InvestorPlace
3 Sleeper Stocks to Buy Now Before 2022 Rolls In
2021 is almost over and it produced many ideas for stocks to buy on weakness. Here are three that may recapture investor attention next year. 
Via InvestorPlace
7 Meme Stocks to Sell Before They Lose Momentum
Meme stocks run the gamut from senseless to sensible. These seven unfortunately fall in the former camp, so steer clear. 
Via InvestorPlace
Top 10 Meme Stocks of 2021 and How They’ll Fare in 2022
Retail investors continue to price meme stocks higher. So it's time to look at 10 meme stocks and consider how they'll fare in 2022. 
Via InvestorPlace
Clover Health: 3 Key Factors That Are Worrisome and 1 That Brings Hope
CLOV stock has underperformed in 2021, became a meme stock, and now has many risks and challenges to face to reach profitability. 
Via InvestorPlace
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.